C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2006
11/16/2006	WO2006122147A2 Alginate poly-l-lysine encapsulation as a technology for controlled differentiation of embryonic stem cells
11/16/2006	WO2006121923A2 Cns cells in vitro
11/16/2006	WO2006121612A1 Treatment of joint disease, methods and apparatuses therefor
11/16/2006	WO2006121445A2 Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media
11/16/2006	WO2006121428A1 Use of nk cell inhibition to facilitate persistence of engrafted mhc- i negative cells
11/16/2006	WO2006121422A2 Antibodies against clostridium difficile toxins and uses thereof
11/16/2006	WO2006121178A1 Method for transformation using mutant acetolactate synthase gene
11/16/2006	WO2006121168A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006	WO2006121159A1 Humanized cdr-grafted antibody specifically reacting with cd10 and antibody fragment of the same
11/16/2006	WO2006121136A1 Method for determination of endoplasmic reticulum stress
11/16/2006	WO2006121047A1 Method for determination of megsin in biological sample
11/16/2006	WO2006121043A1 Culture method for mesenchymal stem cell and process for production of supporting material for biological tissue
11/16/2006	WO2006120575A2 Tcr-independent activation of t cells with co-lignation of cd28 and cd81
11/16/2006	WO2006120476A1 Materials and methods relating to cell based therapies
11/16/2006	WO2006120439A2 Cellular vaccine and use thereof
11/16/2006	WO2006120434A1 Method of fetal cell enrichment
11/16/2006	WO2006119727A1 Expansion medium for the in vitro cultivation of stem cells method for the multiplication of stem cells in vitro and use of the stem cells multiplied by said method
11/16/2006	WO2006119647A1 Oligonucleotides and methods of use
11/16/2006	WO2006102643A3 Stably transformed bone marrow-derived cells and uses thereof
11/16/2006	WO2006053245A3 Retroviral vectors with introns
11/16/2006	WO2006047515A3 Dendritic cells loaded with heat shocked melanoma cell bodies
11/16/2006	WO2006034228A3 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
11/16/2006	WO2005108556A3 Isolation damper and method of forming airtight seal
11/16/2006	WO2003073916A8 Immune regulation
11/16/2006	US20060260015 Somatic embryogenesis and embryo harvesting and method and apparatus for preparing plant embryos for plant production
11/16/2006	US20060260013 Root-specific phosphate transporter promoters
11/16/2006	US20060260012 Method of transforming soybean
11/16/2006	US20060260008 vectors, transformed host cells that contain nucleic acid segments that encode the disclosed delta -endotoxin polypeptides; Bacillus thuringiensis cell
11/16/2006	US20060259997 Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
11/16/2006	US20060259996 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders
11/16/2006	US20060259994 Cathepsin-associated genetically modified nonhuman mammal
11/16/2006	US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060259989 Sporadic tumor mouse model for drug discovery
11/16/2006	US20060259247 Apparatus and method for automated protein design
11/16/2006	US20060259122 Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
11/16/2006	US20060258848 Human antipneumococcal antibodies from non-human animals
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258603 Transposon-based targeting system
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006	US20060258004 Cell sodding method and apparatus
11/16/2006	US20060258003 Culture medium composition, culture method, and myoblasts obtained, and their uses
11/16/2006	US20060258001 Skin substitutes with improved purity
11/16/2006	US20060258000 Use of steady-state oxygen gradients to modulate animal cell functions
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/16/2006	US20060257971 Antibodies to pro1561 polypeptide
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257948 determining whether a treatment of a disorder with an HDAC inhibitor is to be started/continued or not by determining the level of histone acetylation in the sample using an antibody capable of binding to acetylated histone
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257909 Methods for reducing the percentage of abnormal gametes
11/16/2006	US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257872 Cell lines and host nucleic acid sequences related to infectious disease
11/16/2006	US20060257868 Tissue specific genes and gene clusters
11/16/2006	US20060257431 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006	US20060257404 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
11/16/2006	US20060257399 Mixture comprising n-glycan modified antibodies exhibiting increased antibody-dependent cellular cytoxicity (ADCC); targeted destruction of tumor cells
11/16/2006	US20060257394 Modified antibody fab fragments
11/16/2006	US20060257383 Human skin equivalents expressing exogenous polypeptides
11/16/2006	US20060257382 Corneal cells expressing active agents and methods of use thereof
11/16/2006	US20060257381 Method for transplanting lymphohematopoietic cells into mammal
11/16/2006	US20060257380 Use of sirnas for gene silencing in antigen presenting cells
11/16/2006	US20060257376 Improves the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function
11/16/2006	US20060257371 Adenoviral vectors for treating diseases
11/16/2006	US20060257370 Adenoviral vectors for treating diseases
11/16/2006	US20060257367 Tumour-cell specific gene expression and its use in cancer therapy
11/16/2006	US20060257366 Chimeric glycoproteins and pseudotyped lentiviral vectors
11/16/2006	DE102005022032A1 Expansionsmedium zur in vitro Kultivierung von Stammzellen, Verfahren zur Vermehrung von Stammzellen in vitro und Verwendung der nach dem Verfahren vermehrten Stammzellen Expansion medium for culturing stem cells in vitro, method for propagating stem cells in vitro and use of stem cells propagated according to the method
11/16/2006	DE102005021034A1 Verfahren zur Kultivierung einer Zellkultur in einem automatisierten Zellkultursystem sowie automatisiertes Zellkultursystem Method of cultivating a cell culture in an automated cell culture system and automated cell culture system
11/16/2006	CA2608103A1 Screening assays for compounds regulating dj-i expression
11/16/2006	CA2608058A1 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
11/16/2006	CA2608048A1 Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media
11/16/2006	CA2607645A1 Method for transformation using mutant acetolactate synthase gene
11/16/2006	CA2607213A1 Use of nk cell inhibition to facilitate persistence of engrafted mhc- i negative cells
11/16/2006	CA2607147A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006	CA2606287A1 Peptide
11/15/2006	EP1721987A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
11/15/2006	EP1721986A1 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
11/15/2006	EP1721985A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
11/15/2006	EP1721984A2 Method for cloning and expression of the NheI restriction endonuclease in E. coli
11/15/2006	EP1721981A1 Recombinant varicella-zoster virus
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1721977A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
11/15/2006	EP1721976A1 Modified promoter
11/15/2006	EP1721972A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
11/15/2006	EP1721968A1 In vitro tumor angiogenesis model
11/15/2006	EP1721967A1 Method of differentiating mesenchymal stem cells into steroid-producing cells
11/15/2006	EP1720990A2 High efficiency peptide production in plant cells
11/15/2006	EP1720988A2 METHOD FOR PRODUCING UNSATURATED &ohgr;3 FATTY ACIDS IN TRANSGENIC ORGANISMS
11/15/2006	EP1720987A1 Control of programmed death (pcd) in plants
11/15/2006	EP1720980A2 Treatment of spinal conditions
11/15/2006	EP1720979A1 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
11/15/2006	EP1720978A1 Magnetic manipulation of biological samples
11/15/2006	EP1720972A1 Process for cell culturing by continuous perfusion and alternating tangential flow

1 ... 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 ... 1827